Merck & Co., Inc. is 388.2x more valuable than Jade Biosciences, Inc. by market capitalization ($293.16 B vs $755.21 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | JBIO | MRK |
|---|---|---|
| Market cap | $755.21 M | $293.16 B |
| US-listed rank | #2665 | #44 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | -$127.41M | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 479 | 996 |
Merck & Co., Inc. is 388.2x more valuable than Jade Biosciences, Inc. by market capitalization ($293.16 B vs $755.21 M).
Full pages: Jade Biosciences, Inc. and Merck & Co., Inc., or browse the full rankings.